These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32371505)

  • 1. Systematic literature review of the burden and outcomes of infections due to multidrug-resistant organisms in Europe: the ABOUT-MDRO project protocol.
    Anaya-Baz B; Maldonado N; Palacios-Baena ZR; Palomo V; Pezzani MD; Chiesi S; Razzaboni E; Compri M; Tacconelli E; Rodriguez-Baño J
    BMJ Open; 2020 May; 10(5):e030608. PubMed ID: 32371505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of bloodstream infections caused by six key antibiotic-resistant pathogens for prioritization of research and discovery of new therapies in Europe: a systematic review.
    Pezzani MD; Arieti F; Rajendran NB; Barana B; Cappelli E; De Rui ME; Galia L; Hassoun-Kheir N; Argante L; Schmidt J; Rodriguez-Bano J; Harbarth S; de Kraker M; Gladstone BP; Tacconelli E
    Clin Microbiol Infect; 2024 Mar; 30 Suppl 1():S4-S13. PubMed ID: 38007387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global antimicrobial resistance and antibiotic use in COVID-19 patients within health facilities: A systematic review and meta-analysis of aggregated participant data.
    Yang X; Li X; Qiu S; Liu C; Chen S; Xia H; Zeng Y; Shi L; Chen J; Zheng J; Yang S; Tian G; Liu G; Yang L
    J Infect; 2024 Jul; 89(1):106183. PubMed ID: 38754635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol.
    Babu Rajendran N; Gladstone BP; Rodríguez-Baño J; Sifakis F; Voss A; Carmeli Y; Burkert FR; Gkolia P; Tacconelli E
    BMJ Open; 2017 Jan; 7(1):e013634. PubMed ID: 28057656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EUropean prospective cohort study on
    Gutiérrez-Gutiérrez B; Sojo-Dorado J; Bravo-Ferrer J; Cuperus N; de Kraker M; Kostyanev T; Raka L; Daikos G; Feifel J; Folgori L; Pascual A; Goossens H; O'Brien S; Bonten MJ; Rodríguez-Baño J;
    BMJ Open; 2017 Apr; 7(4):e015365. PubMed ID: 28373258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of multidrug resistant organism acquisition in an adult specialist burns service: a retrospective review.
    Cleland H; Tracy LM; Padiglione A; Stewardson AJ
    Antimicrob Resist Infect Control; 2022 Jun; 11(1):82. PubMed ID: 35698209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical prediction models for multidrug-resistant organism colonisation or infection in critically ill patients: a systematic review protocol.
    Wang Y; Xiao Y; Yang Q; Wang F; Wang Y; Yuan C
    BMJ Open; 2022 Sep; 12(9):e064566. PubMed ID: 36175101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Association Between Gastric Acid Suppression and Risk of Intestinal Colonization With Multidrug-Resistant Microorganisms: A Systematic Review and Meta-analysis.
    Willems RPJ; van Dijk K; Ket JCF; Vandenbroucke-Grauls CMJE
    JAMA Intern Med; 2020 Apr; 180(4):561-571. PubMed ID: 32091544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis.
    Nellums LB; Thompson H; Holmes A; Castro-Sánchez E; Otter JA; Norredam M; Friedland JS; Hargreaves S
    Lancet Infect Dis; 2018 Jul; 18(7):796-811. PubMed ID: 29779917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SHIELD Orange County Project: Multidrug-resistant Organism Prevalence in 21 Nursing Homes and Long-term Acute Care Facilities in Southern California.
    McKinnell JA; Singh RD; Miller LG; Kleinman K; Gussin G; He J; Saavedra R; Dutciuc TD; Estevez M; Chang J; Heim L; Yamaguchi S; Custodio H; Gohil SK; Park S; Tam S; Robinson PA; Tjoa T; Nguyen J; Evans KD; Bittencourt CE; Lee BY; Mueller LE; Bartsch SM; Jernigan JA; Slayton RB; Stone ND; Zahn M; Mor V; McConeghy K; Baier RR; Janssen L; O'Donnell K; Weinstein RA; Hayden MK; Coady MH; Bhattarai M; Peterson EM; Huang SS
    Clin Infect Dis; 2019 Oct; 69(9):1566-1573. PubMed ID: 30753383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of falls prevention interventions on falls outcomes for hospitalised adults: protocol for a systematic review with meta-analysis.
    Slade SC; Carey DL; Hill AM; Morris ME
    BMJ Open; 2017 Nov; 7(11):e017864. PubMed ID: 29133324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Risk Factors for Multidrug-Resistant Organisms in Community-Acquired Bacterial Pneumonia at a Community Hospital.
    Covington EW; Rufe A
    J Pharm Pract; 2023 Apr; 36(2):303-308. PubMed ID: 34406082
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of carbapenems versus alternative antimicrobials for treating complicated urinary tract infections caused by antimicrobial-resistant Gram-negative bacteria: protocol for a systematic review and meta-analysis.
    Maeda M; Hasegawa T; Noma H; Ota E
    BMJ Open; 2023 Apr; 13(4):e069166. PubMed ID: 37085310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excess resource use and cost of drug-resistant infections for six key pathogens in Europe: a systematic review and Bayesian meta-analysis.
    Kingston R; Vella V; Pouwels KB; Schmidt JE; Abdelatif El-Abasiri RA; Reyna-Villasmil E; Hassoun-Kheir N; Harbarth S; Rodríguez-Baño J; Tacconelli E; Arieti F; Gladstone BP; de Kraker MEA; Naylor NR; Robotham JV;
    Clin Microbiol Infect; 2024 Mar; 30 Suppl 1():S26-S36. PubMed ID: 38128781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk perception of the antimicrobial resistance by infection control specialists in Europe: a case-vignette study.
    Birgand G; Mutters NT; Ahmad R; Tacconelli E; Lucet JC; Holmes A;
    Antimicrob Resist Infect Control; 2020 Feb; 9(1):33. PubMed ID: 32059746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance Systems from Public Health Institutions and Scientific Societies for Antimicrobial Resistance and Healthcare-Associated Infections in Europe (SUSPIRE): protocol for a systematic review.
    Núñez-Núñez M; Navarro MD; Gkolia P; Babu Rajendran N; Del Toro MD; Voss A; Sharland M; Sifakis F; Tacconelli E; Rodríguez-Baño J;
    BMJ Open; 2017 Mar; 7(3):e014538. PubMed ID: 28348192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systematic Review of the Burden of Multidrug-Resistant Healthcare-Associated Infections Among Intensive Care Unit Patients in Southeast Asia: The Rise of Multidrug-Resistant Acinetobacter baumannii.
    Teerawattanapong N; Panich P; Kulpokin D; Na Ranong S; Kongpakwattana K; Saksinanon A; Goh BH; Lee LH; Apisarnthanarak A; Chaiyakunapruk N
    Infect Control Hosp Epidemiol; 2018 May; 39(5):525-533. PubMed ID: 29580299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A targeted infection prevention intervention in nursing home residents with indwelling devices: a randomized clinical trial.
    Mody L; Krein SL; Saint S; Min LC; Montoya A; Lansing B; McNamara SE; Symons K; Fisch J; Koo E; Rye RA; Galecki A; Kabeto MU; Fitzgerald JT; Olmsted RN; Kauffman CA; Bradley SF
    JAMA Intern Med; 2015 May; 175(5):714-23. PubMed ID: 25775048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of carbapenem-resistant organisms and other Gram-negative MDRO in German ICUs: first results from the national nosocomial infection surveillance system (KISS).
    Maechler F; Peña Diaz LA; Schröder C; Geffers C; Behnke M; Gastmeier P
    Infection; 2015 Apr; 43(2):163-8. PubMed ID: 25395161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of multidrug resistance on outcomes in hematologic cancer patients with bacterial bloodstream infections.
    Park KH; Jung YJ; Lee HJ; Kim HJ; Maeng CH; Baek SK; Han JJ; Jeon W; Kim DY; Lee YM; Lee MS
    Sci Rep; 2024 Jul; 14(1):15622. PubMed ID: 38972913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.